Tag: #Global Trends

Johnson & Johnson (J&J) has reported that its investigational monoclonal antibody, nipocalimab, successfully met its primary clinical endpoint in the... Read more

Bayer has officially announced that new investigational datasets from its Phase III KERENDIA® (finerenone) clinical development program will be showcased... Read more

Alkem Laboratories has officially announced the commercial launch of semaglutide delivered via single-shot pre-filled syringes. With this deployment, Alkem cements... Read more

Singapore’s Health Sciences Authority (HSA) has officially approved MSD’s Enflonsia (clesrovimab). The therapeutic asset is indicated for the prevention of... Read more

Technology giant Microsoft and renowned healthcare network Mayo Clinic have announced a strategic partnership to develop a pioneering frontier artificial... Read more

Diabetes technology leader MiniMed has announced an expanded strategic partnership with Abbott to develop and commercialize proprietary dual glucose-ketone sensors.... Read more

The National Institute for Health and Care Excellence (NICE), the United Kingdom's cost-effectiveness watchdog, has officially recommended AbbVie's targeted "guided... Read more

Pharmaceutical solutions provider Cencora and Gilead Sciences have formally expanded their long-term strategic partnership, which spans more than two decades.... Read more

Pharmaceutical majors Eli Lilly and Boehringer Ingelheim are scaling back their planned capital investments in Germany. Corporate representatives confirmed to... Read more